BALCHEM CORP — Director's Dealing 2022

Feb 17, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2022-02-10

Reporting Person: van Gunsteren Job Leonard (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1401	Direct
Common Stock	1430	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$38.1	2023-02-19	Common Stock (1200)		Direct
Employee Stock Option (right to buy)	$50.32	2024-02-16	Common Stock (4000)		Direct
Employee Stock Option (right to buy)	$58.52	2025-02-19	Common Stock (6000)		Direct
Employee Stock Option (right to buy)	$60.85	2026-02-23	Common Stock (9750)		Direct
Employee Stock Option (right to buy)	$85.4	2027-02-21	Common Stock (5400)		Direct
Employee Stock Option (right to buy)	$74.57	2028-02-15	Common Stock (2600)		Direct
Employee Stock Option (right to buy)	$84.09	2029-02-13	Common Stock (2400)		Direct
Employee Stock Option (right to buy)	$111.94	2030-02-13	Common Stock (2300)		Direct
Employee Stock Option (right to buy)	$119.13	2031-02-11	Common Stock (1800)		Direct
Employee Stock Option (right to buy)	$138.07	2032-02-10	Common Stock (1600)		Direct

Footnotes

F1: Ownership consists of 1,401 shares held directly

F2: Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

F3: Options vest 20% year 1; 40% year 2; and 40% year 3